Aralez Pharmaceuticals Inc (TSE:ARZ) insider James Patrick Tursi bought 4,750 shares of the firm’s stock in a transaction that occurred on Wednesday, March 15th. The shares were acquired at an average cost of C$2.11 per share, for a total transaction of C$10,022.50.
Aralez Pharmaceuticals Inc (TSE:ARZ) traded up 4.30% during trading on Monday, reaching $3.15. The company’s stock had a trading volume of 105,829 shares. The stock has a 50-day moving average of $5.11 and a 200 day moving average of $6.06. Aralez Pharmaceuticals Inc has a one year low of $2.77 and a one year high of $8.75. The firm’s market capitalization is $206.33 million.
var userip;Your IP Address: document.write(userip);
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.